Canaccord Genuity Group Cuts Aurora Cannabis (TSE:ACB) Price Target to C$6.50

Aurora Cannabis (TSE:ACB) had its price objective decreased by Canaccord Genuity Group from C$8.00 to C$6.50 in a research report issued on Friday,BayStreet.CA reports. The firm currently has a “buy” rating on the stock. Canaccord Genuity Group’s price target indicates a potential upside of 52.94% from the company’s current price.

Separately, TD lowered their price target on shares of Aurora Cannabis to C$8.00 and set a “buy” rating on the stock in a report on Friday. Three investment analysts have rated the stock with a Buy rating, According to data from MarketBeat.com, Aurora Cannabis has an average rating of “Buy” and a consensus target price of C$7.67.

Aurora Cannabis Trading Down 0.7%

TSE ACB traded down C$0.03 on Friday, hitting C$4.25. 371,398 shares of the stock were exchanged, compared to its average volume of 412,147. The company’s 50-day moving average price is C$4.77 and its two-hundred day moving average price is C$5.31. The company has a debt-to-equity ratio of 25.02, a current ratio of 3.06 and a quick ratio of 2.48. Aurora Cannabis has a 52-week low of C$3.77 and a 52-week high of C$9.33. The company has a market capitalization of C$251.29 million, a price-to-earnings ratio of -2.83 and a beta of 0.17.

Aurora Cannabis (TSE:ACB) last posted its quarterly earnings results on Thursday, June 11th. The company reported C($0.99) EPS for the quarter. Aurora Cannabis had a negative net margin of 1.69% and a negative return on equity of 1.15%. The company had revenue of C$38.01 million for the quarter. Research analysts predict that Aurora Cannabis will post -0.22 EPS for the current year.

About Aurora Cannabis

Aurora Cannabis, headquartered in Edmonton, Canada, cultivates and sells medicinal and recreational cannabis through a portfolio of brands that includes Aurora, CanniMed, Daily Special, MedReleaf, and San Rafael ’71. Although the company primarily operates in Canada, it has expanded internationally through medical cannabis exporting agreements or cultivation facilities in more than 20 countries.